The Summit’s 2022 Analytical & Quality stream offers in-depth updates on critical steps in biopharmaceutical development that impact product quality, safety, and regulatory compliance. Separate two-day meetings in this stream will focus on the detection, analysis and removal of host cell proteins and the acceleration of analytical development steps and timelines. Over thirty in-depth presentations will give attendees insight into the best practices being applied across large and small industry R&D groups.  

Conferences Include:

Keynote Presentations

Analytical Support for Accelerated Development Timelines
Stephan O. Krause, PhD, CMC Strategy Director, Global Quality, AstraZeneca Biologics


High‐Risk Host Cell Proteins: A Multi‐Company Collaborative View
Nisha Palackal, PhD, Director, Protein Biochemistry, Regeneron Pharmaceuticals, Inc.